Disease Overview：Diabetic Peripheral Neuropathy（DPN）
Diabetic peripheral neuropathy (DPN) is a common, progressive complication of diabetes mellitus characterized by damage to peripheral nerves—primarily sensory, motor, and autonomic—due to chronic hyperglycemia, oxidative stress, microvascular dysfunction, and metabolic derangements. Symptoms typically begin distally in the feet and may include numbness, tingling, burning pain, allodynia, loss of protective sensation, and muscle weakness; severe cases risk foot ulcers, Charcot neuroarthropathy, and lower-limb amputation. Diagnosis relies on clinical assessment, nerve conduction studies (NCS), quantitative sensory testing (QST), and corneal confocal microscopy—tools increasingly integrated into routine evaluation in advanced centers. Early intervention focuses on strict glycemic control, lifestyle modification, and pharmacologic management (e.g., duloxetine, pregabalin, or topical capsaicin), while emerging modalities—including neuromodulation, intravenous alpha-lipoic acid, and regenerative approaches—are gaining evidence-based traction.
China offers distinct advantages for DPN management: leading endocrinology departments—such as those at Peking Union Medical College Hospital and Shanghai Jiao Tong University Affiliated Sixth People’s Hospital—combine deep expertise in diabetic complications with access to high-resolution NCS systems, real-time ultrasound-guided nerve blocks, and clinical trial participation in novel neuroprotective agents. Success rates in symptom reduction and functional stabilization align with international benchmarks, supported by longitudinal cohort data from China’s National Diabetes Registry. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising diagnostic rigor or therapeutic standards. As a dedicated medical tourism agency, we facilitate seamless care for international patients—vetting accredited hospitals, coordinating multidisciplinary consultations, providing itemized, transparent pricing in advance, and offering end-to-end support including visa assistance, medical translation, and post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Diabetic Peripheral Neuropathy (Endocrinology Department)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Symptomatic neuropathy (pain, numbness, burning), HbA1c ≤9.0%, no active foot ulcer/infection, eGFR ≥30 mL/min.
- •First-line pharmacotherapy (per 30-day supply):
- *Pregabalin:* ¥95–¥210 ($13–$30) - *Gabapentin:* ¥42–¥115 ($6–$16)
- •Glucose optimization (3-month endocrinology management package):
- •Neuropathy-specific diagnostics:
- Quantitative sensory testing (QST): ¥320 ($45) - Monofilament exam + vibration perception threshold (VPT): ¥85 ($12)
Surgical / Procedural / Interventional Options
*Eligibility:* Refractory pain (>6 months despite dual-medication trial), confirmed small-fiber neuropathy on skin biopsy, no contraindications to local anesthesia, absence of Charcot neuroarthropathy or active infection.
- •Ultrasound-guided peripheral nerve blocks (e.g., tibial/sural nerve):
- Series of 3 (recommended for sustained effect): ¥5,100–¥7,200 ($715–$1,010)
- •Preoperative workup (mandatory):
- Electrophysiological confirmation (NCS/EMG): ¥680–¥920 ($95–$130)
Special / Complex Condition Options
- •Severe autonomic involvement (e.g., gastroparesis + orthostatic hypotension):
- •Neuropathic foot ulcer with subclinical infection (no cellulitis):
Quick Selection Guide
- •<60 years, mild-moderate pain, budget < $200/month: Start with *gabapentin* + strict glycemic control (HbA1c target <7.0%). Total 3-month cost: ~$250.
- •60–75 years, moderate-severe pain, comorbid CKD (eGFR 45–60): *Duloxetine* + quarterly NCS monitoring. Avoid pregabalin/gabapentin. Total 6-month cost: ~$420.
- •>75 years, refractory pain + falls risk, budget > $1,000: Ultrasound-guided nerve block series + home-based balance rehab. Total procedural + rehab cost: ~$1,250.
- •Any age, rapid progression + autonomic symptoms: Expedited IVIG + autonomic function testing (tilt-table + HRV analysis: ¥1,150 / $160). Total initial cost: ~$2,760.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Diabetic Peripheral Neuropathy Medical Vacation Packages
Curated transparent all-inclusive packages combining Diabetic Peripheral Neuropathy treatment with China top medical destinations:
